Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF1535 NEXThaler versus pMDI for rapid relief of methacholine-induced bronchoconstriction in asthma
2016-003672-47Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of beclometasone dipropionate + formoterol in asthma (3 arms), sponsored by Chiesi Farmaceutici S.p.A. Started Nov 2016; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2016-003672-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003672-47.